- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
- Uses
-
Warnings
For nasal use only. Ask a doctor before use if you have
- heart disease
- thyroid disease
- high blood pressure
- diabetes
- trouble urinating due to an enlarged prostate gland
When using this product
- do not exceed recommended dosage
- temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge may occur
- do not use for more than 3 days. Frequent or prolonged use may cause nasal congestion to come back or get worse.
- use only as directed
- Directions
- Inactive Ingredients
- PRINCIPAL DISPLAY PANEL - 1/2 FL. OZ. Bottle Carton
-
INGREDIENTS AND APPEARANCE
NOSTRILLA
oxymetazoline hydrochloride spray, meteredProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63736-072 Route of Administration NASAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Oxymetazoline Hydrochloride (UNII: K89MJ0S5VY) (Oxymetazoline - UNII:8VLN5B44ZY) Oxymetazoline 0.0005 mL in 100 mL Inactive Ingredients Ingredient Name Strength benzalkonium chloride (UNII: F5UM2KM3W7) camphor (UNII: 5TJD82A1ET) carboxymethylcellulose sodium (UNII: K679OBS311) edetate disodium (UNII: 7FLD91C86K) eucalyptol (UNII: RV6J6604TK) glycine (UNII: TE7660XO1C) menthol (UNII: L7T10EIP3A) polyethylene glycol (UNII: 3WJQ0SDW1A) propylene glycol (UNII: 6DC9Q167V3) sodium hydroxide (UNII: 55X04QC32I) water (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63736-072-01 1 in 1 CARTON 1 15 mL in 1 BOTTLE, SPRAY Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part341 06/08/2009 Labeler - Insight Pharmaceuticals (176792315)